Please login to the form below

Not currently logged in
Email:
Password:

Imara

This page shows the latest Imara news and features for those working in and with pharma, biotech and healthcare.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m

In return, Arix owns 10% of the company and Investment Director Mark Chin will join Imara’s board of directors. ... This financing is an important milestone for Imara as it seeks to progress its treatments to patients.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...